An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection-Reference-Cited by-同舟云学术

An Integrated Metabolomic and Microbiome Analysis Identified Specific Gut Microbiota Associated with Fecal Cholesterol and Coprostanol in Clostridium difficile Infection

Published:2016-02-12 Issue:2 Volume:11 Page:e0148824
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Antharam Vijay C.,McEwen Daniel C.,Garrett Timothy J.,Dossey Aaron T.,Li Eric C.,Kozlov Andrew N.,Mesbah Zhubene,Wang Gary P.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease;AN Ananthakrishnan;Gut,2008

2. Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea;VC Antharam;J Clin Microbiol,2013

3. Fecal bacteriotherapy for recurrent Clostridium difficile infection;JS Bakken;Anaerobe,2009

4. Clostridium difficile: controversies and approaches to management;MP Bauer;Curr Opin Infect Dis,2009

5. “Flora Power”—fecal bacteria cure chronic C. difficile diarrhea;TJ Borody;The Am J Gastroenterol,2000

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut microbiome and plasma lipidome analysis reveals a specific impact of Clostridioides difficile infection on intestinal bacterial communities and sterol metabolism;mBio;2024-08-27

2. Interplay between Bile Acids and Intestinal Microbiota: Regulatory Mechanisms and Therapeutic Potential for Infections;Pathogens;2024-08-20

3. Fecal microbiota and concentrations of long-chain fatty acids, sterols, and unconjugated bile acids in cats with chronic enteropathy;Frontiers in Veterinary Science;2024-06-12

4. Investigating the influence of the gut microbiome on cholelithiasis: unveiling insights through sequencing and predictive modeling;Journal of Applied Microbiology;2024-04-13

5. Probiotics, gut microbiome, and cardiovascular diseases: An update;Transplant Immunology;2024-04